Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
General23 hours agoSA couple’s wedding vinyl returns home after 56 years and 10,000km trek
-
General21 hours agoAlex De Minaur powers through to Washington Open semifinals with win over Brandon Nakashima
-
Noosa News24 hours ago“This Makes You One of the Most-Powerful Supes in the World”: The Trailer for ‘Gen V’ Season Two Is Here
-
Noosa News22 hours agoFather pays tribute to his daughter Sophia Rose after she was killed by mother Lauren Flanigan